STAGE III DISTAL BILE DUCT CANCER AJCC V8
Clinical trials for STAGE III DISTAL BILE DUCT CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III DISTAL BILE DUCT CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III DISTAL BILE DUCT CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug combo enters first human safety tests
Disease control OngoingThis is an early-stage safety study testing a new drug called BAY 1895344 when given with standard chemotherapy drugs (cisplatin with or without gemcitabine). The main goals are to find the safest dose and understand the side effects in people with advanced solid tumors that have…
Matched conditions: STAGE III DISTAL BILE DUCT CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for Tough-to-Treat bile duct cancers
Disease control OngoingThis study is for people with advanced bile duct, gallbladder, or liver bile duct cancer that has worsened after initial treatment. It tests whether adding a targeted pill called binimetinib to standard chemotherapy (FOLFOX) helps patients live longer and better control the cance…
Matched conditions: STAGE III DISTAL BILE DUCT CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC